| European Medicines Agency, CAT Secretariat & US Food and Drug Administration. | |
| | |
MedLine Citation:
|
PMID: 21999268 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The European Medicines Agency (EMA) and the Committee for Advanced Therapies (CAT) are responsible for reviewing applications for marketing authorization for Advanced Therapy Medicinal Products (ATMP), which include (stem) cell-based medicines, for the ATMP classification and certification procedure, and to provide scientific advice to developers of ATMPs. The CAT, an expert committee dedicated to ATMPs, was established by the Regulation (EC) No 1394/2007 on Advanced Therapies. The CAT came into operation in January 2009. ATMPs are defined in this Regulation as gene therapy and cell therapy medicinal products, and tissue-engineered products. The US FDA's Center for Biologics Evaluation and Research is responsible for ensuring the safety, purity, potency and effectiveness of many biologically derived products, including blood intended for transfusion, blood components and derivatives, vaccines and allergenic extracts, and cell, tissue and gene therapy products for the prevention, diagnosis and treatment of human diseases, conditions or injury. Human cells or tissue intended for implantation, transplantation, infusion or transfer into a human recipient are regulated as human cells, tissues, and cellular and tissue-based products (HCT/Ps). |
| | |
Authors:
|
- |
Related Documents
:
|
10808988 - A threat to the public health workforce: evidence from trends in preventive medicine ce... 22274818 - Low molecular weight heparin biosimilars: how much similarity for how much clinical ben... 22591628 - European association of urology guidelines on male infertility: the 2012 update. 22302418 - Setting pay for performance targets: do poor performers give up? 17373948 - Efficiency of traps for stomoxys calcitrans and stomoxys niger niger on reunion island. 10575538 - The third therapeutic revolution: behavioral medicine. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Regenerative medicine Volume: 6 ISSN: 1746-076X ISO Abbreviation: Regen Med Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-10-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101278116 Medline TA: Regen Med Country: England |
Other Details:
|
Languages: eng Pagination: 90-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Brüstle v. Greenpeace: implications for stem cell research.
Next Document: Medicare coverage: engaging on evidence.